Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
4,171,333
-
Share change
-
-1,382,660
-
Total reported value
-
$18,361,000
-
Put/Call ratio
-
165%
-
Price per share
-
$4.40
-
Number of holders
-
57
-
Value change
-
-$8,087,326
-
Number of buys
-
36
-
Number of sells
-
16
Institutional Holders of ADAMIS PHARMACEUTICALS CORP - COM NEW (ADMP) as of Q4 2017
As of 31 Dec 2017,
ADAMIS PHARMACEUTICALS CORP - COM NEW (ADMP) was held by
57 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,171,333 shares.
The largest 10 holders included
Vanguard Group Inc, SUSQUEHANNA INTERNATIONAL GROUP, LLP, BlackRock Inc., B. Riley Financial, Inc., Balyasny Asset Management LLC, GEODE CAPITAL MANAGEMENT, LLC, BARD ASSOCIATES INC, Leisure Capital Management, MORGAN STANLEY, and BARCLAYS PLC.
This page lists
57
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.